Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 31

Analysis: Manbang Group goes public

A number of corporate backers scored an exit from trucking services marketplace Full Truck Alliance (Manbang Group), as the latter went public in the US. This transaction exemplifies an upward trend in exits for corporate-backed businesses from the transport and mobility space.

Jun 28, 2021

Xpeng drives to dual-listed IPO

The EV manufacturer, backed by Alibaba, Duowan, Foxconn, UCar and Xiaomi, has filed to float in Hong Kong, and will potentially raise almost $2bn.

Jun 25, 2021

Abbisko aims for Hong Kong IPO

The AstraZeneca, Sinopharm and Eli Lilly-backed oncology drug developer has revealed its intention to go public in a Hong Kong IPO that could reportedly fetch $250m.

Jun 25, 2021

Monte Rosa blows through $222m IPO

GV notched up an exit as cancer therapy developer Monte Rosa Therapeutics priced an upsized initial public offering at the top of its range.

Jun 25, 2021

Sprinklr settles for $266m in IPO

Intel Capital-backed customer experience software provider Sprinklr floated below its range in its initial public offering.

Jun 24, 2021

Confluent concocts $828m initial public offering

LinkedIn's data streaming spinoff, Confluent, is floating above its range in an offering effectively doubling the valuation of its last funding round to over $9bn.

Jun 24, 2021

Soulgate shuts off IPO plans

The Tencent-backed social media app developer was aiming to raise $198m in the offering but has withdrawn in favour of alternative financing options.

Jun 24, 2021

Nostromo lists shares through Somoto merger

Shell, Taavura Group and Menora Mivtachim-backed Nostromo secured $13.6m through a reverse merger with publicly-listed Somoto.

Jun 24, 2021

Full Truck Alliance parks itself in public markets

SoftBank, Tencent, Alphabet and Baidu-backed trucking services marketplace Full Truck Alliance has gone public in an offering sized at close to $1.57bn.

Jun 23, 2021

Pear Therapeutics seeks fruits of reverse takeover

SoftBank and Novartis-backed digital therapeutics provider Pear has agreed a reverse merger at a $1.6bn pro forma equity valuation.

Jun 23, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here